Michael Cronquist Christensen

3.0k total citations
81 papers, 2.1k citations indexed

About

Michael Cronquist Christensen is a scholar working on Pharmacology, Experimental and Cognitive Psychology and Neurology. According to data from OpenAlex, Michael Cronquist Christensen has authored 81 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Pharmacology, 28 papers in Experimental and Cognitive Psychology and 16 papers in Neurology. Recurrent topics in Michael Cronquist Christensen's work include Treatment of Major Depression (41 papers), Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (21 papers) and Mental Health Research Topics (17 papers). Michael Cronquist Christensen is often cited by papers focused on Treatment of Major Depression (41 papers), Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (21 papers) and Mental Health Research Topics (17 papers). Michael Cronquist Christensen collaborates with scholars based in Denmark, United States and United Kingdom. Michael Cronquist Christensen's co-authors include Henrik Loft, Roger S. McIntyre, Ioana Florea, Stephen Morris, Christian von Heymann, Angela Kempel, Andrea Fagiolini, Vicki Munro, Stephan A. Mayer and Christian S. van der Hilst and has published in prestigious journals such as Stroke, Critical Care Medicine and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

Michael Cronquist Christensen

77 papers receiving 2.1k citations

Peers

Countries citing papers authored by Michael Cronquist Christensen

Since Specialization

Citations

This map shows the geographic impact of Michael Cronquist Christensen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Cronquist Christensen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Cronquist Christensen more than expected).

Fields of papers citing papers by Michael Cronquist Christensen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Cronquist Christensen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Cronquist Christensen. The network helps show where Michael Cronquist Christensen may publish in the future.

Co-authorship network of co-authors of Michael Cronquist Christensen

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Cronquist Christensen. A scholar is included among the top collaborators of Michael Cronquist Christensen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Cronquist Christensen. Michael Cronquist Christensen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Goal Attainment Scaling for Depression: Validation of the Japanese GAS-D Tool in Patients with Major Depressive Disorder 2024 ·Neuropsychiatric Disease and Treatment ·Masaki Kato, Toshiaki Kikuchi, Koichiro Watanabe, Tomiki Sumiyoshi, Yoshiya Moriguchi, Daniel Oudin Åström, Michael Cronquist Christensen	2
2	Assessing Reliability and Validity of the Oxford Depression Questionnaire (ODQ) in a Japanese Clinical Population 2023 ·Neuropsychiatric Disease and Treatment ·Masaki Kato, Toshiaki Kikuchi, Koichiro Watanabe, Tomiki Sumiyoshi, Yoshiya Moriguchi, Daniel Oudin Åström, Michael Cronquist Christensen	0
3	Clinical benefits of vortioxetine 20 mg/day in patients with major depressive disorder 2023 ·CNS Spectrums ·Michael Cronquist Christensen, Roger S. McIntyre, (unknown), Ioana Florea, Henrik Loft, Andrea Fagiolini	13
4	Head-To-Head Comparison of Vortioxetine Versus Desvenlafaxine in Patients With Major Depressive Disorder With Partial Response to SSRI Therapy 2023 ·The Journal of Clinical Psychiatry ·Roger S. McIntyre, Ioana Florea, Mads Møller Pedersen, Michael Cronquist Christensen	21
5	Effectiveness of vortioxetine in patients with major depressive disorder and comorbid Alzheimer’s disease in routine clinical practice: An analysis of a post-marketing surveillance study in South Korea 2023 ·Frontiers in Aging Neuroscience ·Eduardo Cumbo, (unknown), Daniel Oudin Åström, Michael Cronquist Christensen	10
6	Emotional blunting in patients with depression. Part II: relationship with functioning, well-being, and quality of life 2022 ·Annals of General Psychiatry ·Michael Cronquist Christensen, Hongye Ren, Andrea Fagiolini	11
7	Effectiveness of Vortioxetine in Patients With Major Depressive Disorder in Real-World Clinical Practice: Results of the RELIEVE Study 2022 ·Frontiers in Psychiatry ·Gregory W. Mattingly, Hongye Ren, Michael Cronquist Christensen, Martin A. Katzman, Mircea Polosan, (unknown), Lene Hammer-Helmich	27
8	Emotional blunting in patients with depression. Part III: relationship with psychological trauma 2022 ·Annals of General Psychiatry ·Michael Cronquist Christensen, Hongye Ren, Andrea Fagiolini	5
9	Efficacy of vortioxetine in patients with major depressive disorder reporting childhood or recent trauma 2019 ·Journal of Affective Disorders ·Michael Cronquist Christensen, Ioana Florea, Henrik Loft, Roger S. McIntyre	17
10	A Subgroup Analysis of the Impact of Vortioxetine on Functional Capacity, as Measured by UPSA, in Patients with Major Depressive Disorder and Subjective Cognitive Dysfunction 2018 ·The International Journal of Neuropsychopharmacology ·Richard S.E. Keefe, George G. Nomikos, Wei Zhong, Michael Cronquist Christensen, W. Jacobson	2
11	Vortioxetine improves symptomatic and functional outcomes in major depressive disorder: A novel dual outcome measure in depressive disorders 2017 ·Journal of Affective Disorders ·Michael Cronquist Christensen, Henrik Loft, Roger S. McIntyre	35
12	Cost per successfully treated patient for vortioxetine versus duloxetine in adults with major depressive disorder: an analysis of the complete symptoms of depression and functional outcome 2017 ·Current Medical Research and Opinion ·Michael Cronquist Christensen, Vicki Munro	6
13	Global Differences in Causes, Management, and Survival After Severe Trauma: The Recombinant Activated Factor VII Phase 3 Trauma Trial 2010 ·The Journal of Trauma: Injury, Infection, and Critical Care ·Michael Cronquist Christensen, Michael Parr, Bartholomew J. Tortella, Johan Malmgren, Stephen Morris, Todd W. Rice, John B. Holcomb	8
14	Costs of excessive postoperative hemorrhage in cardiac surgery 2009 ·Journal of Thoracic and Cardiovascular Surgery ·Michael Cronquist Christensen, (unknown), Angela Kempel, Christian von Heymann	120
15	Depressed Mood after Intracerebral Hemorrhage: The FAST Trial 2009 ·Cerebrovascular Diseases ·Michael Cronquist Christensen, Stephan A. Mayer, (unknown), Brett Kissela	57
16	Global Differences in Patient Characteristics, Case Management and Outcomes in Intracerebral Hemorrhage: The Factor Seven for Acute Hemorrhagic Stroke (FAST) Trial 2009 ·Cerebrovascular Diseases ·Michael Cronquist Christensen, Joseph P. Broderick, Catherine Vincent, Stephen Morris, Thorsten Steiner	18
17	Determinants of hospital costs associated with traumatic brain injury in England and Wales* 2008 ·Anaesthesia ·Stephen Morris, S. Ridley, Fiona Lecky, Vicki Munro, Michael Cronquist Christensen	25
18	Ischemic Stroke and Intracerebral Hemorrhage: The Latest Evidence on Mortality, Readmissions and Hospital Costs from Scotland 2008 ·Neuroepidemiology ·Michael Cronquist Christensen, Vicki Munro	32
19	Morbidity and mortality among elderly Americans with different stroke subtypes 2007 ·Advances in Therapy ·Won Chan Lee, Ashish V. Joshi, Qin Wang, Chris L. Pashos, Michael Cronquist Christensen	27
20	Long-Term Mortality, Morbidity and Hospital Care following Intracerebral Hemorrhage: An 11-Year Cohort Study 2006 ·Cerebrovascular Diseases ·Alistair McGuire, Maria Raikou, Ian R. Whittle, Michael Cronquist Christensen	40

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact